July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Wee Joo Chng: Presenting the Role of Superenhancers in Myeloma at the 2025 Asian Oncology Summit
Jul 5, 2025, 12:46

Wee Joo Chng: Presenting the Role of Superenhancers in Myeloma at the 2025 Asian Oncology Summit

Wee Joo Chng, Vice President of Biomedical Science Research at National University of Singapore, shared a post on LinkedIn:

“I am so happy to be invited to present our work on ‘The role of superenhancers in Myeloma’ at the 2025 Asian Oncology Summit in Seoul.

It is not often that I get asked to present on our science, although our group published as much (if not more) on the science and biology of Myeloma than the clinical aspect!

Wee Joo Chng: Presenting the Role of Superenhancers in Myeloma at the 2025 Asian Oncology Summit

For those interested in the topic of Superenhancers in Blood Cancers, below are the links to papers we have published on this topic:

Title: Super enhancer acquisition drives expression of oncogenic PPP1R15B that regulates protein homeostasis in multiple myeloma

Authors: Sinan Xiong, Jianbiao Zhou, Tze King Tan, Tae-Hoon Chung, Tuan Zea Tan, Sabrina Hui-Min Toh, Nicole Xin Ning Tang, Yunlu Jia, Yi Xiang See, Melissa Jane Fullwood, Takaomi Sanda and Wee-Joo Chng

You can read the Full Article in Nature Communications.

Wee Joo Chng: Presenting the Role of Superenhancers in Myeloma at the 2025 Asian Oncology Summit

Title: Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma

Authors: Yunlu Jia, Jianbiao Zhou, Tze King Tan, Tae-Hoon Chung, Yongxia Chen, Jing-Yuan Chooi, Takaomi Sanda, Melissa J. Fullwood, Sinan Xiong, Sabrina H.M. Toh, Kalpnaa Balan, Regina W.J. Wong, Julia S.L. Lim, Enfan Zhang, Zhen Cai, Peng Shen, Wee Joo Chng.

You can read the Full Article in Cancer Research.

Wee Joo Chng: Presenting the Role of Superenhancers in Myeloma at the 2025 Asian Oncology Summit

Title: Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma

Authors: Yunlu Jia, Jianbiao Zhou, Tze King Tan, Tae-Hoon Chung, Regina Wan Ju Wong, Jing-Yuan Chooi, Julia Sze Lynn Lim, Takaomi Sanda, Melissa Ooi, Sanjay De Mel, Cinnie Soekojo, Yongxia Chen, Enfan Zhang, Zhen Cai, Peng Shen, Jian Ruan, Wee-Joo Chng

You can read the Full Article in Blood Cancer Journal.

Wee Joo Chng: Presenting the Role of Superenhancers in Myeloma at the 2025 Asian Oncology Summit

Title: Super-enhancer-driven TOX2 mediates oncogenesis in Natural Killer/T Cell Lymphoma

Authors: Jianbiao Zhou, Sabrina Hui-Min Toh, Tze King Tan, Kalpnaa Balan, Jing Quan Lim, Tuan Zea Tan, Sinan Xiong, Yunlu Jia, Siok-Bian Ng, Yanfen Peng, Anand D. Jeyasekharan, Shuangyi Fan, Soon Thye Lim, Chin-Ann Johnny Ong, Choon Kiat Ong, Takaomi Sanda, Wee-Joo Chng

You can read the Full Article in Molecular Cancer.

Wee Joo Chng: Presenting the Role of Superenhancers in Myeloma at the 2025 Asian Oncology Summit

Title: Super-enhancers: critical roles and therapeutic targets in hematologic malignancies

Authors: Yunlu Jia, Wee-Joo Chng, Jianbiao Zhou

You can read the Full Article in the Journal of Hematology and Oncology.

Wee Joo Chng: Presenting the Role of Superenhancers in Myeloma at the 2025 Asian Oncology Summit

More posts featuring Wee Joo Chng.